Working… Menu

WBRT & Erlotinib in Advanced NSCLC and Brain Metastases (TACTIC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00554775
Recruitment Status : Terminated (IDMC made a recommendation to stop the trial as the target for continuing to the 2nd phase was not met.)
First Posted : November 7, 2007
Last Update Posted : December 12, 2011
Cancer Research UK
Roche Pharma AG
Information provided by (Responsible Party):
University College, London

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : November 2010
Actual Study Completion Date : November 2010